| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/30/2003 | EP1330236A2 Formulation containing amoxicillin |
| 07/30/2003 | EP1330221A2 Medical compositions, dressings and methods for treating microbial infections of skin lesions |
| 07/30/2003 | EP1330166A1 Food grade transglutaminase inhibitor and uses thereof |
| 07/30/2003 | EP1252141B1 Tosylproline analogs as thymidylate synthase inhibitors |
| 07/30/2003 | EP1187817B1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/30/2003 | EP1184388B1 Sulphostin analogues and processes for the preparation of sulphostin and analogues thereof |
| 07/30/2003 | EP1181288B1 Bicyclic oxazolidinones as antibacterial agent |
| 07/30/2003 | EP1144406B1 Antifungal azole derivatives having a fluorinated vinyl group and process for preparing same |
| 07/30/2003 | EP1082962B1 Utilization of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factors nf-(k)b |
| 07/30/2003 | EP1075256B1 Arylhydrocarbon receptor ligand antagonists |
| 07/30/2003 | EP1012146B1 Hiv nuclear localization inhibitors |
| 07/30/2003 | EP0946558B1 Ethylidene derivatives of tricyclic carbapenems |
| 07/30/2003 | EP0946541B1 Quinolines and their therapeutic use |
| 07/30/2003 | EP0935461B1 Adamantane amine derivatives for the treatment of viruses of the bornaviridae family |
| 07/30/2003 | EP0910376B1 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 07/30/2003 | EP0859628B1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 07/30/2003 | EP0835252B1 Triazole antifungal agents |
| 07/30/2003 | EP0833923B1 Immunogenic construct, process for its preparation and use as a vaccine |
| 07/30/2003 | EP0832198B1 Oxygen activatable formulations for disinfection or sterilization |
| 07/30/2003 | CN2562768Y Anti-infection wound adhesive plaster |
| 07/30/2003 | CN1433472A Production of vaccines |
| 07/30/2003 | CN1433471A 85Kgda neisserial antigen |
| 07/30/2003 | CN1433469A Therapeutically useful synthetic oligonucleotides |
| 07/30/2003 | CN1433466A MASP-3, complement-fixing enzyme, and uses for it |
| 07/30/2003 | CN1433430A Hepatitis virus sentinel virus I (SVI) |
| 07/30/2003 | CN1433423A Mono and disaccharide derivatives |
| 07/30/2003 | CN1433414A Benzazole derivatives and their use as JNK modulators |
| 07/30/2003 | CN1433413A Novel oxazolidinone derivatives and process for the preparation thereof |
| 07/30/2003 | CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/30/2003 | CN1433411A Chemical compounds |
| 07/30/2003 | CN1433408A Aminothiazole inhibitors of cyslin dependent kinases |
| 07/30/2003 | CN1433406A BenzoÒÇöaÒÇòphenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and Ôàí" |
| 07/30/2003 | CN1433396A Pharmaceutical compounds |
| 07/30/2003 | CN1433322A Compositions comprising nei sseria meningitidis antigens from serogroups B and C |
| 07/30/2003 | CN1433319A Enzyme treatment for infection |
| 07/30/2003 | CN1433318A Vascular endothelial growth factor-2 |
| 07/30/2003 | CN1433317A Use of immunosuppessant for increasing antifungal activity of lipopetide |
| 07/30/2003 | CN1433316A Biologically active agents and drugs |
| 07/30/2003 | CN1432408A Prepn process of cow mammitis vaccine |
| 07/30/2003 | CN1432391A Recipe of Chinese medicine with treating and health care functions |
| 07/30/2003 | CN1432385A Hepatitis B treating medicine pill |
| 07/30/2003 | CN1432384A Ointment for removing necrosis, promoting granulation and invigorating bone and its prepn |
| 07/30/2003 | CN1432375A Dog pestilence treating medicine composition |
| 07/30/2003 | CN1432373A Nano granules for preventing AIDS and infectious viral blood disease |
| 07/30/2003 | CN1432371A Ginseng-astragalus-glutinous rehmannia injection and its prepn |
| 07/30/2003 | CN1432365A Veterinary antivirus injection and its prepn |
| 07/30/2003 | CN1432361A Antibiotics medicine for injection |
| 07/30/2003 | CN1432357A Fever allaying prepn containing xylitol |
| 07/30/2003 | CN1116306C Composition and pharmaceutical preparation contg. same for treatment of herpes and related viral infections |
| 07/30/2003 | CN1116304C Organic compound |
| 07/30/2003 | CN1116301C Tetracyclic fluoquinolone carboxylic acid, its preparing process and medicinal composition containing it as active component |
| 07/30/2003 | CN1116300C Tetracyclic fluoquinolone carboxylic acid, its preparing process and medicinal composition containing it as active component |
| 07/30/2003 | CN1116299C Crystalline substance of cefditoren pivoxyl and prodn. of same |
| 07/30/2003 | CN1116293C Preparation of dihydromyricetrin |
| 07/30/2003 | CN1116288C Urea derivatives as inhibitors of inosine-5'-phospho-dehydrogenase |
| 07/30/2003 | CN1116282C Bisulfate salt of HIV protease inhibitor |
| 07/30/2003 | CN1116281C Acryloyl substituted distamycin derivative, process for preparing them,and use as antitumor and antiviral agents |
| 07/30/2003 | CN1116054C Phthisis treating Chinese herbal medicine |
| 07/30/2003 | CN1116043C Process for preparation of coated azithromycin micropill |
| 07/30/2003 | CN1116034C Acyl urea compounds for treatment of coccidioidomycosis in warmblooded animals |
| 07/30/2003 | CN1116033C Effervescent tablets for curing vaginities and its preparing method |
| 07/30/2003 | CA2369711A1 Macrocyclic peptides active against the hepatitis c virus |
| 07/29/2003 | US6600063 Novel antimycobacterial compounds and in particular to antimycobacterial compounds comprised of derivatives of phenyl 4-aminosalicylate. This invention further relates to methods for their preparation, to form drugs |
| 07/29/2003 | US6600035 6-(substituted methylene) penems and intermediates |
| 07/29/2003 | US6600032 Compound for use in the treatment of viral, protozoan and parasitic infections |
| 07/29/2003 | US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis |
| 07/29/2003 | US6600028 Tricyclic base analogues |
| 07/29/2003 | US6600027 Polynucleotide molecules encoding neospora proteins |
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6599945 Methods for treating subjects infected with a herpes virus |
| 07/29/2003 | US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity |
| 07/29/2003 | US6599930 Coniosetin and derivatives thereof, process for the preparation and the use thereof |
| 07/29/2003 | US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| 07/29/2003 | US6599911 Arylsulfonic acid salts of pyrimidine-based antiviral agents |
| 07/29/2003 | US6599910 Substituted triazole compounds |
| 07/29/2003 | US6599896 Use of tianeptine in the production of medicaments to treat neurodegenerative pathologies |
| 07/29/2003 | US6599895 β-lactam compounds and process for producing the same |
| 07/29/2003 | US6599893 Such as (7R)-7-(2-(2-amino-5-chlorothiazol-4-yl)-2-trityl-oxyiminoacetylamino)-3-(4 -methyl-(1,2, 3)thiadiazol-5-ylsulfanyl)-8-oxo-5-thia-1-aza-bicyclo(4.2.0)oct-2-ene-2 -carboxylic acid benzhydryl ester; methicillin-resistance |
| 07/29/2003 | US6599892 Beta-lactamase inhitiors |
| 07/29/2003 | US6599890 Inhibitors of matrix metalloproteinases or the production of tumor necrosis factor |
| 07/29/2003 | US6599886 Macrolide intermediates in the preparation of clarithromycin |
| 07/29/2003 | US6599884 Slurrying a solid comprising clarithromycin Form 0 in water; macrolide antibiotic related to erythromycin A |
| 07/29/2003 | US6599880 Analog further comprises an amino acid substitution; for treating gram-negative bacterial infections in a subject |
| 07/29/2003 | US6599874 Isolated from human milk for prophylactic and/or therapeutic treatment of infections caused by bacteria, in particular Streptococcus pneumoniae and Haemophilus influenzae in upper and lower airways, ear-nose-and-throat infections |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599528 Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances |
| 07/29/2003 | US6599508 Truncated papillomavirus L1 protein, vaccine |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | CA2288038C Polyethylene glycol-interferon alpha conjugates for therapy of infection |
| 07/29/2003 | CA2189971C Vaccine for moraxella catarrhalis |
| 07/29/2003 | CA2189474C Compositions having antiviral properties and preparation process |
| 07/29/2003 | CA2114136C Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them |
| 07/29/2003 | CA2097931C Salmonella vaccines |
| 07/29/2003 | CA2093664C Modified ribozymes |
| 07/29/2003 | CA2056345C Optically active pyridobenzoxazine derivatives |
| 07/29/2003 | CA2012125C Use of functional derivatives of the intercellular adhesion molecule icam-1 in anti-viral therapy |
| 07/28/2003 | CA2398226A1 Increased-dosage nelfinavir tablet and method of making same |
| 07/24/2003 | WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060143A2 Efficient protein expression system |